---
figid: PMC4477307__12885_2015_1360_Fig10_HTML
figlink: /pmc/articles/PMC4477307/figure/Fig10/
number: F10
caption: 'Cooperative disruption of signaling network downstream of mutated KRAS.
  Schematic view of KRAS/PAK1/Crk signaling pathway is demonstrated. Partial inhibition
  of KRAS signaling output by tolerable dose of prenylation inhibitors (i.e., FTI + GGTI)
  in addition to inhibition of a prominent KRAS effector (i.e., PAK1) result in dramatic
  anti-tumor effects. FTI: farnesyltransferase inhibitor, GGTI: geranylgeranyltransferase
  inhibitor, PAK1I: p21 associated kinase 1 inhibitor.'
pmcid: PMC4477307
papertitle: Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis.
reftext: Fariborz Mortazavi, et al. BMC Cancer. 2015;15:381.
pmc_ranked_result_index: '8916'
pathway_score: 0.9307267
filename: 12885_2015_1360_Fig10_HTML.jpg
figtitle: Cooperative disruption of signaling network downstream of mutated KRAS
year: '2015'
organisms:
- Homo sapiens
ndex: 033e9012-df0a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4477307__12885_2015_1360_Fig10_HTML.html
  '@type': Dataset
  description: 'Cooperative disruption of signaling network downstream of mutated
    KRAS. Schematic view of KRAS/PAK1/Crk signaling pathway is demonstrated. Partial
    inhibition of KRAS signaling output by tolerable dose of prenylation inhibitors
    (i.e., FTI + GGTI) in addition to inhibition of a prominent KRAS effector (i.e.,
    PAK1) result in dramatic anti-tumor effects. FTI: farnesyltransferase inhibitor,
    GGTI: geranylgeranyltransferase inhibitor, PAK1I: p21 associated kinase 1 inhibitor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - MAP2K1
  - PGGT1B
  - MAPK3
  - MAP2K2
  - MAPK1
  - PAK1
  - KRAS
  - TIAM1
  - RALGDS
  - CDH1
  - ARAF
  - RAF1
  - SNAI1
  - SOS1
  - RAC1
  - BAD
  - CRK
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: GGTI
  symbol: GGTI
  source: hgnc_alias_symbol
  hgnc_symbol: PGGT1B
  entrez: '5229'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PAK1
  symbol: PAK1
  source: hgnc_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Tiam1
  symbol: TIAM1
  source: hgnc_symbol
  hgnc_symbol: TIAM1
  entrez: '7074'
- word: RalGDS
  symbol: RALGDS
  source: hgnc_symbol
  hgnc_symbol: RALGDS
  entrez: '5900'
- word: E-cadherin/
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: (sos1
  symbol: SOS1
  source: hgnc_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Crk
  symbol: CRK
  source: hgnc_symbol
  hgnc_symbol: CRK
  entrez: '1398'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4477307__F10
redirect_from: /figures/PMC4477307__F10
figtype: Figure
---
